These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3184242)
1. The utilization of bacilli as larvicidal agents against anopheline and culicine mosquitoes in Turkey. I. Larvicidal activity of Bacillus thuringiensis serotype H-14. Matur A; Ceber K J Trop Med Hyg; 1988 Oct; 91(5):229-30. PubMed ID: 3184242 [TBL] [Abstract][Full Text] [Related]
2. Laboratory and field efficacy of Bacillus thuringiensis var. Israelensis and Bacillus sphaericus against Anopheles gambiae s.l. and Culex quinquefasciatus in Ouagadougou, Burkina Faso. Majori G; Ali A; Sabatinelli G J Am Mosq Control Assoc; 1987 Mar; 3(1):20-5. PubMed ID: 3504891 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of a flowable concentrate formulation of Bacillus thuringiensis (H-14) against larval mosquitoes in southern Iran. Zaim M; Kasiri H; Motabar M J Am Mosq Control Assoc; 1992 Jun; 8(2):156-8. PubMed ID: 1279118 [TBL] [Abstract][Full Text] [Related]
4. Residual activity of Bacillus thuringiensis serovars medellin and jegathesan on Culex pipiens and Aedes aegypti larvae. Thiéry I; Fouque F; Gaven B; Lagneau C J Am Mosq Control Assoc; 1999 Sep; 15(3):371-9. PubMed ID: 10480130 [TBL] [Abstract][Full Text] [Related]
5. Small scale field trials with Bacillus thuringiensis variety israelensis H-14 strain against larvae of anopheline and culicine mosquitoes. Sharma SK; Kalra NL; Bhargava YS J Commun Dis; 1983 Dec; 15(4):223-34. PubMed ID: 6674325 [No Abstract] [Full Text] [Related]
6. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species. Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266 [TBL] [Abstract][Full Text] [Related]
7. Host range and selected factors influencing the mosquito larvicidal activity of the PG-14 isolate of Bacillus thuringiensis var. morrisoni. Lacey LA; Lacey CM; Padua LE J Am Mosq Control Assoc; 1988 Mar; 4(1):39-43. PubMed ID: 3193097 [TBL] [Abstract][Full Text] [Related]
8. Indoor thermal fogging against vector mosquitoes with two Bacillus thuringiensis israelensis formulations, Vectobac ABG 6511 water-dispersible granules and Vectobac 12AS liquid. Yap HH; Lee YW; Zairi J J Am Mosq Control Assoc; 2002 Mar; 18(1):52-6. PubMed ID: 11998931 [TBL] [Abstract][Full Text] [Related]
9. [Experimental observation of toxic effect of Bacillus thuringiensis var. israelensis against Aedes, Culex and Anopheles larvae]. Li JL; Zhu GD; Zhou HY; Tang JX; Cao J Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Feb; 26(1):67-8. PubMed ID: 24800571 [TBL] [Abstract][Full Text] [Related]
10. Field trials with Vectolex (Bacillus sphaericus) and Vectobac (Bacillus thuringiensis (H-14)) against Anopheles gambiae and Culex quinquefasciatus breeding in Zaire. Karch S; Manzambi ZA; Salaun JJ J Am Mosq Control Assoc; 1991 Jun; 7(2):176-9. PubMed ID: 1895075 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Bacillus thuringiensis israelensis, Bacillus sphaericus and temephos for managing Anopheles larvae in Eritrea. Shililu JI; Tewolde GM; Brantly E; Githure JI; Mbogo CM; Beier JC; Fusco R; Novak RJ J Am Mosq Control Assoc; 2003 Sep; 19(3):251-8. PubMed ID: 14524547 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Czechoslovak and Soviet Bacillus thuringiensis (serotype H-14) formulations against mosquito larvae. Rettich F J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):53-63. PubMed ID: 2883232 [TBL] [Abstract][Full Text] [Related]
13. [Immediate larvicidal activity and residual action of the endotoxin of the serotype H-14 of Bacillus thuringiensis in 2 mosquito biotopes on the French Mediterranean coast]. Sinègre G; Vigo G; Gaven B; Jullien JL Parassitologia; 1980; 22(1-2):213-21. PubMed ID: 7312402 [TBL] [Abstract][Full Text] [Related]
14. Comparative bioassays of Bacillus thuringiensis H-14 formulations against four species of mosquitoes in Malaysia. Foo AE; Yap HH Southeast Asian J Trop Med Public Health; 1982 Jun; 13(2):206-10. PubMed ID: 6128794 [TBL] [Abstract][Full Text] [Related]
15. Development of a self floating slow release formulation of Bacillus thuringiensis var. israelensis and its larvicidal activity. Prabakaran G; Padmanabhan V; Balaraman K Indian J Exp Biol; 2001 Jan; 39(1):82-4. PubMed ID: 11349533 [TBL] [Abstract][Full Text] [Related]
16. Laboratory evaluation of Bacillus thuringiensis (Vectobac WDG) against mosquito larvae, Culex pipiens and Culiseta longiareolata. Boudjelida H; Aïssaoui L; Bouaziz A; Smagghe G; Soltani N Commun Agric Appl Biol Sci; 2008; 73(3):603-9. PubMed ID: 19226801 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of larvicidal effects of Bacillus thuringiensis var. israelensis (serotype H-14) and Bacillus sphaericus preparations and the susceptibility of adult mosquitoes to malarial plasmodia]. Ganushkina LA Med Parazitol (Mosk); 1987; (1):10-3. PubMed ID: 3553885 [No Abstract] [Full Text] [Related]
18. Microdroplet application of mosquitocidal Bacillus thuringiensis using ultra-low-volume generator for the control of mosquitos. Seleena P; Lee HL; Nazni WA; Rohani A; Kadri MS Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):628-32. PubMed ID: 9185282 [TBL] [Abstract][Full Text] [Related]
19. Retention of mosquito larvicidal activity of lyophilized cells and WDP formulation of Bacillus thuringiensis var. israelensis on long-term storage. Manonmani AM; Prabakaran G; Hoti SL Acta Trop; 2008 Feb; 105(2):170-5. PubMed ID: 18155180 [TBL] [Abstract][Full Text] [Related]
20. Larvicidal efficacy of Bacillus sphaericus H-5a, 5b and B. thuringiensis var. israelensis H-14 against malaria vectors in Bhabar area, District Naini Tal, U.P. Shukla RP; Kohli VK; Ojha VP Indian J Malariol; 1997 Dec; 34(4):208-12. PubMed ID: 9699425 [No Abstract] [Full Text] [Related] [Next] [New Search]